{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T18:12:37Z","timestamp":1790878357309,"version":"4.1.0"},"reference-count":40,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,12,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Growing recognition that the ovary is an end organ in sickle cell disease (SCD), advances in SCD treatment and cure, and innovations in assisted reproductive technologies invite progressive challenges in fertility care for women with SCD. The reproductive life span of women with SCD may be reduced because ovarian reserve declines more rapidly in people with SCD compared to unaffected people. Some young women have diminished ovarian reserve, a risk factor for infertility. Referrals for fertility preservation may be offered and anticipatory guidance about when to seek infertility care provided. For a subset of people with SCD, this information is also applicable when pursuing in vitro fertilization with preimplantation genetic testing to avoid implantation of an embryo with SCD. Here we explore the dimensions of SCD-related fertility care illustrated by the case of a 28-year-old woman with hemoglobin SS disease who initially presented for a hematology consultation for preconception counseling. This case highlights the complexity of preconception SCD management and care and the need to partner with patients to help align pregnancy hopes with SCD treatment and the many associated uncertainties.<\/jats:p>","DOI":"10.1182\/hematology.2022000381","type":"journal-article","created":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T16:12:18Z","timestamp":1670602338000},"page":"459-466","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":9,"title":["No crystal stair: supporting fertility care and the pursuit of pregnancy in women with sickle cell disease"],"prefix":"10.1182","volume":"2022","author":[{"given":"Lydia H.","family":"Pecker","sequence":"first","affiliation":[{"name":"1 Division of Hematology, Johns Hopkins University School of Medicine, Baltimore, MD"},{"name":"2 Division of Reproductive Endocrinology and Infertility, Johns Hopkins University School of Medicine, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alecia","family":"Nero","sequence":"additional","affiliation":[{"name":"3 Division of Hematology-Oncology, UT Southwestern Medical Center, Dallas, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mindy","family":"Christianson","sequence":"additional","affiliation":[{"name":"2 Division of Reproductive Endocrinology and Infertility, Johns Hopkins University School of Medicine, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2022,12,9]]},"reference":[{"issue":"6","key":"2022120916091402600_hem2022000381C1","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1111\/bjh.17671","article-title":"Management of sickle cell disease in pregnancy: a British Society for Haematology guideline","volume":"194","author":"Oteng-Ntim","year":"2021","journal-title":"Br J Haematol"},{"issue":"4","key":"2022120916091402600_hem2022000381C2","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s10995-018-2516-z","article-title":"Reproductive life planning: raising the questions","volume":"22","author":"Morse","year":"2018","journal-title":"Matern Child Health J"},{"issue":"1","key":"2022120916091402600_hem2022000381C3","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1182\/hematology.2019000039","article-title":"Complications in pregnant women with sickle cell disease","volume":"2019","author":"Smith-Whitley","year":"2019","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"11","key":"2022120916091402600_hem2022000381C4","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.contraception.2021.08.009","article-title":"Contraceptive use and preferences among females with sickle cell disease","volume":"105","author":"Roe","year":"2022","journal-title":"Contraception"},{"issue":"5","key":"2022120916091402600_hem2022000381C5","first-page":"552","article-title":"Women with sickle cell disease report low knowledge and use of long acting reversible contraception","volume":"113","author":"Pecker","year":"2021","journal-title":"J Natl Med Assoc"},{"issue":"3","key":"2022120916091402600_hem2022000381C6","first-page":"174","article-title":"Contraceptive methods and the impact of menstruation on daily functioning in women with sickle cell disease","volume":"112","author":"Day","year":"2019"},{"issue":"2","key":"2022120916091402600_hem2022000381C7","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1089\/jwh.2018.7147","article-title":"Acute vaso-occlusive pain is temporally associated with the onset of menstruation in women with sickle cell disease","volume":"28","author":"Sharma","year":"2019","journal-title":"J Women's Health"},{"issue":"5","key":"2022120916091402600_hem2022000381C8","doi-asserted-by":"crossref","first-page":"e28227","DOI":"10.1002\/pbc.28227","article-title":"Reproductive intentions in mothers of young children with sickle cell disease","volume":"67","author":"Schultz","year":"2020","journal-title":"Pediatr Blood Cancer"},{"issue":"June","key":"2022120916091402600_hem2022000381C9","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jpeds.2020.04.027","article-title":"Parents of children with sickle cell disease are interested in preimplantation genetic testing","volume":"223","author":"Attia","year":"2020","journal-title":"J Pediatr"},{"issue":"1","key":"2022120916091402600_hem2022000381C10","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1182\/asheducation-2018.1.474","article-title":"The current state of sickle cell trait: implications for reproductive and genetic counseling","volume":"2018","author":"Pecker","year":"2018","journal-title":"Hematology"},{"issue":"1","key":"2022120916091402600_hem2022000381C11","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s10815-021-02358-z","article-title":"Acceptable, hopeful, and useful: development and mixed-method evaluation of an educational tool about reproductive options for people with sickle cell disease or trait","volume":"39","author":"Early","year":"2022","journal-title":"J Assist Reprod Genet"},{"issue":"6","key":"2022120916091402600_hem2022000381C12","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1111\/bjh.17658","article-title":"Knowledge gaps in reproductive and sexual health in girls and women with sickle cell disease","volume":"194","author":"Pecker","year":"2021","journal-title":"Br J Haematol"},{"issue":"6","key":"2022120916091402600_hem2022000381C13","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1111\/bjh.17607","article-title":"Distinct maternal and fetal pregnancy outcomes in women with sickle cell disease can be predicted using routine clinical and laboratory data","volume":"194","author":"Malinowski","year":"2021","journal-title":"Br J Haematol"},{"issue":"2","key":"2022120916091402600_hem2022000381C14","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1182\/bloodadvances.2019001143","article-title":"American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support","volume":"4","author":"Chou","year":"2020","journal-title":"Blood Adv"},{"issue":"5","key":"2022120916091402600_hem2022000381C15","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/ajh.26495","article-title":"Pregnancy outcomes with hydroxyurea use in women with sickle cell disease","volume":"97","author":"Kroner","year":"2022","journal-title":"Am J Hematol"},{"issue":"3","key":"2022120916091402600_hem2022000381C16","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1002\/jha2.478","article-title":"Developmental disorders in children born to women with sickle cell disease: a report from the Boston Birth Cohort","volume":"3","author":"Brucato","year":"2022","journal-title":"EJHaem"},{"issue":"3","key":"2022120916091402600_hem2022000381C17","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.fertnstert.2019.11.025","article-title":"Definitions of infertility and recurrent pregnancy loss: a committee opinion","volume":"113","author":"American Society of Reproductive Medicine Practice Committee","year":"2020","journal-title":"Fertil Steril"},{"issue":"2","key":"2022120916091402600_hem2022000381C18","doi-asserted-by":"crossref","first-page":"e0213024","DOI":"10.1371\/journal.pone.0213024","article-title":"Ovarian reserve in women with sickle cell disease","volume":"14","author":"Kopeika","year":"2019","journal-title":"PLoS One"},{"issue":"1","key":"2022120916091402600_hem2022000381C19","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s13048-021-00927-5","article-title":"Ovarian reserve in Nigerian women with sickle cell anaemia: a cross-sectional study","volume":"14","author":"Garba","year":"2021","journal-title":"J Ovarian Res"},{"issue":"5","key":"2022120916091402600_hem2022000381C20","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1111\/bjh.16976","article-title":"Hydroxycarbamide exposure and ovarian reserve in women with sickle cell disease in the Multicenter Study of Hydroxycarbamide","volume":"191","author":"Pecker","year":"2020","journal-title":"Br J Haematol"},{"issue":"7","key":"2022120916091402600_hem2022000381C21","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1182\/blood.2021012756","article-title":"Diminished ovarian reserve in young women with sickle cell anemia","volume":"139","author":"Pecker","year":"2022","journal-title":"Blood"},{"issue":"4","key":"2022120916091402600_hem2022000381C22","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1177\/15353702211068522","article-title":"Sickle cell disease as an accelerated aging syndrome","volume":"247","author":"Idris","year":"2022","journal-title":"Exp Biol Med (Maywood)"},{"issue":"2","key":"2022120916091402600_hem2022000381C23","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.xfre.2021.08.007","article-title":"Inequity and injustice: recognizing infertility as a reproductive justice issue","volume":"3","author":"Perritt","year":"2022","journal-title":"F&S Rep"},{"issue":"16","key":"2022120916091402600_hem2022000381C24","doi-asserted-by":"crossref","first-page":"3804","DOI":"10.1182\/bloodadvances.2020001743","article-title":"Building access to care in adult sickle cell disease: defining models of care, essential components, and economic aspects","volume":"4","author":"Kanter","year":"2020","journal-title":"Blood Adv"},{"issue":"9","key":"2022120916091402600_hem2022000381C25","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11092318","article-title":"Fertility after curative therapy for sickle cell disease: a comprehensive review to guide care","volume":"11","author":"Nickel","year":"2022","journal-title":"J Clin Med"},{"issue":"3","key":"2022120916091402600_hem2022000381C26","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.htct.2020.06.009","article-title":"Menopause in Brazilian women with sickle cell anemia with and without hydroxyurea therapy","volume":"43","author":"Queiroz","year":"2021","journal-title":"Hematol Transfus Cell Ther"},{"issue":"7","key":"2022120916091402600_hem2022000381C27","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1182\/blood.2021015021","article-title":"Reproductive equity: preserve the reserve","volume":"139","author":"Quinn","year":"2022","journal-title":"Blood"},{"issue":"1","key":"2022120916091402600_hem2022000381C28","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.bcmd.2015.03.012","article-title":"The effects of hydroxyurea and bone marrow transplant on anti-M\u00fcllerian hormone (AMH) levels in females with sickle cell anemia","volume":"55","author":"Elchuri","year":"2015","journal-title":"Blood Cells Mol Dis"},{"issue":"4","key":"2022120916091402600_hem2022000381C29","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.fertnstert.2018.05.016","article-title":"Risks associated with fertility preservation for women with sickle cell anemia","volume":"110","author":"Pecker","year":"2018","journal-title":"Fertil Steril"},{"issue":"26","key":"2022120916091402600_hem2022000381C30","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1182\/blood.2021014473","article-title":"Risk of vaso-occlusive episode after exposure to corticosteroids in patients with sickle cell disease","volume":"139","author":"Walter","year":"2022","journal-title":"Blood"},{"issue":"3","key":"2022120916091402600_hem2022000381C31","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s10815-022-02413-3","article-title":"Preimplantation genetic testing for aneuploidy (PGT-A)\u2014a single-center experience","volume":"39","author":"Nair","year":"2022","journal-title":"J Assist Reprod Genet"},{"issue":"5","key":"2022120916091402600_hem2022000381C32","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/bjh.16930","article-title":"Cumulative outcome of pre-implantation genetic diagnosis for sickle cell disease: a 5-year review","volume":"191","author":"Vali","year":"2020","journal-title":"Br J Haematol"},{"issue":"3","key":"2022120916091402600_hem2022000381C33","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/bjh.14993","article-title":"Approach to transfusion in pregnant women with sickle cell disease: a survey of physicians","volume":"183","author":"Malinowski","year":"2018","journal-title":"Br J Haematol"},{"issue":"7","key":"2022120916091402600_hem2022000381C34","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1182\/bloodadvances.2021005942","article-title":"Sustainability of low maternal mortality in pregnant women with SCD in a low-resource setting","volume":"6","author":"Swarray-Deen","year":"2022","journal-title":"Blood Adv"},{"key":"2022120916091402600_hem2022000381C35","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.placenta.2020.04.003","article-title":"Placental histopathology in sickle cell disease: a descriptive and hypothesis-generating study","volume":"95","author":"Malinowski","year":"2020","journal-title":"Placenta"},{"issue":"6","key":"2022120916091402600_hem2022000381C36","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/bjh.17606","article-title":"Impact of pre-eclampsia on renal outcome in sickle cell disease patients","volume":"194","author":"Boudhabhay","year":"2021","journal-title":"Br J Haematol"},{"issue":"2","key":"2022120916091402600_hem2022000381C37","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1191\/0962280206sm433oa","article-title":"Methodologic issues in the design and analysis of epidemiologic studies of pregnancy outcome","volume":"15","author":"Savitz","year":"2006","journal-title":"Stat Methods Med Res"},{"issue":"2","key":"2022120916091402600_hem2022000381C38","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1017\/jme.2021.34","article-title":"Bounded justice and the limits of health equity","volume":"49","author":"Creary","year":"2021","journal-title":"J Law Med Ethics"},{"issue":"7","key":"2022120916091402600_hem2022000381C39","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1111\/trf.15328","article-title":"Alloimmunization in patients with sickle cell disease and underrecognition of accompanying delayed hemolytic transfusion reactions","volume":"59","author":"Coleman","year":"2019","journal-title":"Transfusion"},{"key":"2022120916091402600_hem2022000381C40","unstructured":"Hughes\n              L\n            \n          . Mother to son. https:\/\/www.poetryfoundation.org\/poems\/47559\/mother-to-son. Accessed 17July2022."}],"container-title":["Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/hematology\/article-pdf\/2022\/1\/459\/2021796\/459pecker.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/hematology\/article-pdf\/2022\/1\/459\/2021796\/459pecker.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T16:12:43Z","timestamp":1670602363000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/hematology\/article\/2022\/1\/459\/493550\/No-crystal-stair-supporting-fertility-care-and-the"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,9]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12,9]]},"published-print":{"date-parts":[[2022,12,9]]}},"URL":"https:\/\/doi.org\/10.1182\/hematology.2022000381","relation":{},"ISSN":["1520-4391","1520-4383"],"issn-type":[{"value":"1520-4391","type":"print"},{"value":"1520-4383","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,12,9]]},"published":{"date-parts":[[2022,12,9]]}}}